Hamilton Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53M Buy
39,706
+1,339
+3% +$188K 1.08% 24
2025
Q4
$4.71M Buy
38,367
+2,208
+6% +$268K 0.9% 30
2025
Q3
$4.01M Buy
36,159
+2,322
+7% +$264K 0.84% 34
2025
Q2
$3.75M Buy
33,837
+11
+0% +$1.17K 0.84% 31
2025
Q1
$3.79M Sell
33,826
-35,091
-51% -$3.62M 0.91% 31
2024
Q4
$6.37M Sell
68,917
-1,132
-2% -$102K 1.54% 18
2024
Q3
$5.87M Buy
70,049
+37,712
+117% +$2.88M 1.44% 21
2024
Q2
$2.22M Buy
32,337
+3,117
+11% +$208K 0.6% 37
2024
Q1
$2.14M Sell
29,220
-27,987
-49% -$2.15M 0.67% 39
2023
Q4
$4.63M Buy
57,207
+25,483
+80% +$1.98M 1.46% 23
2023
Q3
$2.38M Buy
31,724
+377
+1% +$29K 0.85% 25
2023
Q2
$2.42M Sell
31,347
-268
-0.8% -$21.4K 0.84% 28
2023
Q1
$2.62M Sell
31,615
-493
-2% -$40.8K 0.92% 26
2022
Q4
$2.76M Sell
32,108
-57,153
-64% -$4.53M 1.12% 28
2022
Q3
$5.51M Buy
89,261
+2,640
+3% +$166K 2.33% 14
2022
Q2
$5.35M Buy
86,621
+18,913
+28% +$1.17M 2.1% 17
2022
Q1
$4.03M Buy
+67,708
New +$4.33M 1.75% 19
2020
Q4
Sell
-50,984
Closed -$3.22M 55
2020
Q3
$3.22M Buy
50,984
+481
+1% +$33.4K 1.8% 21
2020
Q2
$3.89M Sell
50,503
-23,687
-32% -$1.82M 2.32% 20
2020
Q1
$5.55M Buy
74,190
+47,308
+176% +$3.27M 4.14% 6
2019
Q4
$1.75M Buy
+26,882
New +$1.75M 1.18% 25

Other funds holding GILD

Hamilton Wealth's GILD Position: Q1 2026 in Review

Hamilton Wealth increased its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, buying an estimated $188K and bringing the position to 39,706 shares worth $5.53M. The position accounts for 1.08% of the portfolio, ranked #24.

Hamilton Wealth first reported a position in GILD in Q4 2019 and has held it in 21 quarters since. The position peaked at $6.37M in Q4 2024. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hamilton Wealth held 39,706 shares of Gilead Sciences worth $5.53M as of Q1 2026.
  • Hamilton Wealth bought 1,339 Gilead Sciences shares in Q1 2026, an estimated $188K.
  • Gilead Sciences made up 1.08% of Hamilton Wealth's portfolio in Q1 2026, its #24 holding.
  • Hamilton Wealth first reported a position in Gilead Sciences in Q4 2019 and has held it in 21 quarters since.
  • Hamilton Wealth's Gilead Sciences position peaked at $6.37M in Q4 2024.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.